Clinical trial
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00000299 |
|---|---|
| Title | Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2 |
| Official title | Rapid Opiate Detoxification & Naltrexone Induction Using Bup. |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Opioid-Related Disorders |
| Intervention type | Drug |
| Interventions | Buprenorphine |
| Enrollment | 12 |
| Start date | Oct 1, 2008 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 21, 1999 |
| Last update posted | Jan 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: